| 1995 | Folia Pharm. Univ. Carol. 19 | Pag. 21—27 |
Alice Lázníčková1 (laznicko@faf.cuni.cz), František Budský2, Milan Lázníček1
1Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
2Nuclear Research Centre, Řež near Prague, Czech Republic
In this work the conditions for 99mTc-labelling of two phosphonate compounds EDTMP (ethylenediamine-N,N,N',N'-tetrakis (methylene phosphonic acid)) and DCHMP (diaminecyclohexane-N,N,N',N'-tetrakis (methylene phsphonic acid)) and their biodistribution in rats were studied for sceletal scintigraphy purposes. Both 99mTc-chelates studied cleared rapidly from the blood and non-osseous tissues and selectively localized in the bone. A significant portion of radioactivity was found also in the kidney due to their glomerular filtration from the blood. 99mTc-DCHMP was shown as alternative bone scintigraphy agent with near biodistribution and complexing ability to other commonly used 99mTc-bone radiopharmaceuticals.